Nervio News
2 articles
growth-positive
Nervio appoints Dr. Richard Vogel as US CEO | CTech
Nervio, a company specializing in AI-based neurophysiologist support systems, has appointed Dr. Richard Vogel as its U.S. CEO. The company is expanding its U.S. operations and raising a post-Seed round, supplemented by a grant from the Israel Innovation Authority. Nervios technology aims to support neurophysiologists in managing the increasing demand for spine surgeries, which are expected to rise by 40% over the next decade. The AI system, developed over five years, is designed to reduce workload and improve patient care. Dr. Vogel, a leader in neurophysiological monitoring, sees this as a significant advancement in the field, providing much-needed support to the workforce.
Management ChangesInvestmentExpand
growth-positive
10 Israeli companies selected for Assuta's 'RISE With US' program | CTech
Assuta Medical Centers innovation arm, Rise, has announced the 10 startups selected for the second cohort of its RISE with US program. The program aims to connect startups to the global healthcare market, with a focus on the American market. The startups, chosen from 111 applicants, are developing digital health solutions using artificial intelligence and big data. The program is supported by AWS and Nvidia, as well as venture capital funds from LionBird and eHealth Ventures. The startups will have access to Assuta Medical Centers, receive clinical guidance from physicians, and gain access to a network of contacts in the healthcare industry.
PartnersInvestment
